Optimal first‐line treatment for advanced thymic carcinoma

BACKGROUND: Thymic carcinomas (TCs) are rare aggressive tumors with no standard first‐line treatment. This study was conducted to determine the optimal chemotherapy regimen for advanced TC. METHODS: This retrospective study included 67 patients treated for stage IV TC in 2006–2015. The primary endpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Zhuo, Minglei, Shi, Anhui, Yang, Shengnan, Wang, Ziping, Wu, Meina, An, Tongtong, Wang, Yuyan, Li, Jianjie, Zhong, Jia, Chen, Hanxiao, Jia, Bo, Dong, Zhi, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825903/
https://www.ncbi.nlm.nih.gov/pubmed/31574576
http://dx.doi.org/10.1111/1759-7714.13181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825903/
https://www.ncbi.nlm.nih.gov/pubmed/31574576
http://dx.doi.org/10.1111/1759-7714.13181

Ejemplares similares